BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2124219)

  • 1. Evaluation of the interaction of lithium and alprazolam.
    Evans RL; Nelson MV; Melethil S; Townsend R; Hornstra RK; Smith RB
    J Clin Psychopharmacol; 1990 Oct; 10(5):355-9. PubMed ID: 2124219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of venlafaxine on the pharmacokinetics of alprazolam.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    Psychopharmacol Bull; 1998; 34(2):211-9. PubMed ID: 9641003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma.
    Labbate LA; Pollack MH; Otto MW; Tesar GM; Rosenbaum JF
    J Clin Psychopharmacol; 1994 Aug; 14(4):274-6. PubMed ID: 7962684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.
    Smith RB; Gwilt PR; Wright CE
    Clin Pharm; 1983; 2(2):139-43. PubMed ID: 6883942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
    Marr MA; Djuric PE; Ritschel WA; Garver DL
    Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers.
    Breuel HP; Müller-Oerlinghausen B; Nickelsen T; Heine PR
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):415-9. PubMed ID: 7582400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of flurbiprofen on steady-state plasma lithium levels.
    Hughes BM; Small RE; Brink D; McKenzie ND
    Pharmacotherapy; 1997; 17(1):113-20. PubMed ID: 9017771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.
    Hamzeh FM; Benson C; Gerber J; Currier J; McCrea J; Deutsch P; Ruan P; Wu H; Lee J; Flexner C;
    Clin Pharmacol Ther; 2003 Mar; 73(3):159-69. PubMed ID: 12621381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of lithium-nonsteroidal anti-inflammatory drug interactions.
    Ragheb M
    J Clin Psychopharmacol; 1990 Oct; 10(5):350-4. PubMed ID: 2258452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam kinetics following sublingual and oral administration.
    Scavone JM; Greenblatt DJ; Shader RI
    J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
    Greene DS; Salazar DE; Dockens RC; Kroboth P; Barbhaiya RH
    J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine.
    Lau CE; Wang Y; Falk JL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1013-29. PubMed ID: 9190832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initiating thymoregulator treatment].
    Olié JP; Launay C; Poirier MF
    Encephale; 1995 Mar; 21 Spec No 2():71-8. PubMed ID: 7588183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL
    Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of lithium in the elderly.
    Hardy BG; Shulman KI; Mackenzie SE; Kutcher SP; Silverberg JD
    J Clin Psychopharmacol; 1987 Jun; 7(3):153-8. PubMed ID: 3110219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal clearance technic for individualizing lithium dosage in routine hospital care].
    Klinger E; Steimer JL; Jouvent R; Le Moël G; Mascart JY; Des Lauriers A
    Encephale; 1984; 10(5):223-30. PubMed ID: 6440774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ; Wright CE
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.